PFE Dividend: Pfizer Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	62,786	63,627	59,554	101,175	81,288	41,651
Revenue Growth (YoY)	4%	7%	-41%	24%	95%	1%
Cost of Revenue	15,727	16,332	17,789	34,097	30,686	8,405
Gross Profit	47,059	47,295	41,765	67,078	50,602	33,246
Selling, General & Admin	13,836	14,617	14,446	13,049	12,109	11,402
Research & Development	10,132	10,738	10,578	11,426	11,579	9,340
Operating Expenses	28,776	30,566	28,669	26,292	23,067	23,093
Other Non Operating Income (Expenses)	--	--	1	2	--	-1
Pretax Income	9,153	8,023	1,058	34,729	24,311	7,036
Income Tax Expense	-685	-28	-1,115	3,328	1,852	370
Net Income	9,828	8,031	2,119	31,372	21,979	9,159
Net Income Growth	131%	279%	-93%	43%	140%	-44%
Shares Outstanding (Diluted)	5,714	5,700	5,709	5,733	5,708	5,632
Shares Change (YoY)	0%	0%	0%	0%	1%	-1%
EPS (Diluted)	1.72	1.41	0.37	5.47	3.85	1.62
EPS Growth	132%	281%	-93%	42%	138%	-43%
Free Cash Flow	10,376	9,835	4,793	26,031	29,869	11,612
Free Cash Flow Per Share	1.81	1.72	0.83	4.54	5.23	2.06
Gross Margin	74.95%	74.33%	70.12%	66.29%	62.25%	79.82%
Operating Margin	29.11%	26.29%	21.99%	40.31%	33.87%	24.37%
Profit Margin	15.65%	12.62%	3.55%	31%	27.03%	21.98%
Free Cash Flow Margin	16.52%	15.45%	8.04%	25.72%	36.74%	27.87%
EBITDA	23,287	22,015	17,829	44,395	31,235	13,501
EBITDA Margin	37.08%	34.6%	29.93%	43.87%	38.42%	32.41%
D&A For EBITDA	5,004	5,286	4,733	3,609	3,700	3,348
EBIT	18,283	16,729	13,096	40,786	27,535	10,153
EBIT Margin	29.11%	26.29%	21.99%	40.31%	33.87%	24.37%
Effective Tax Rate	-7.48%	-0.34%	-105.38%	9.58%	7.61%	5.25%

Pfizer Inc (PFE) Price